STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
X
Recruiting
- Leukemia, Myeloid, Acute
- anti-CD33 CAR NK cells
- +2 more
- Chongqing, Chongqing, ChinaDepartment of Hematology, Xinqiao Hospital
2021-12-22
Dec 22, 2021W
Active, not recruiting
- Leukemia, Myeloid, Acute
- New York, New YorkWeill Cornell Medical College
2021-12-10
Dec 10, 2021X
Not yet recruiting
- Leukemia, Myeloid, Acute
- Fludarabine
- +2 more
- Chongqing, Chongqing, ChinaDepartment of Hematology, Xinqiao Hospital
2021-08-20
Aug 20, 2021M
Not yet recruiting
- Leukemia, Myeloid, Acute
- Liposomal Annamycin
- Cytarabine
- Poznań, PolandSzpital Kliniczny Przemienienia Pańskiego Uniwersytetu Medyczneg
2022-04-05
Apr 5, 2022B
Not yet recruiting
- Myelodysplastic Syndromes
- +2 more
- (no location specified)
2022-01-20
Jan 20, 2022C
Recruiting
- Leukemia
- +2 more
- CD123 CAR-T cells
- Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
2021-03-01
Mar 1, 2021C
Recruiting
- Leukemia
- +2 more
- CD123 CAR-T cells
- Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force
2021-03-01
Mar 1, 2021Z
Recruiting
- Leukemia, Myeloid, Acute
- Guanzhou, Guandong, ChinaNanfang Hospital of Southern Medical University
2022-03-06
Mar 6, 2022P
Recruiting
- Leukemia, Lymphoblastic
- Leukemia, Myeloid, Acute
- This study is observational
- Bauru, São Paulo, BrazilFaculdade de Odontologia de Bauru, Universidade de São Paulo
2021-07-08
Jul 8, 2021N
Recruiting
- Acute Myeloid Leukemia
- Taipei, TaiwanNational Taiwan University Hospital
2021-10-27
Oct 27, 2021M
Completed
- Leukemia, Myeloid, Acute
- Liposomal Annamycin
- La Jolla, California
- +3 more
2022-02-28
Feb 28, 2022P
A
Enrolling by invitation
- Leukemia, Myeloid, Acute
- +2 more
- observation only
- Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
2021-03-29
Mar 29, 2021T
Completed
- Acute Myeloid Leukemia, Relapsed, Adult
- CDIAG regimen
- Suzhou, Jiangsu, ChinaThe First Affliated Hospital of Soochow University
2022-03-16
Mar 16, 2022L
Completed
- Leukemia, Myelogenous, Acute
- Charlotte, North CarolinaLevine Cancer Institute
2021-11-05
Nov 5, 2021U
Recruiting
- Leukemia, Myeloid, Acute
- Minimal Residual Disease
- Chapel Hill, North CarolinaNorth Carolina Cancer Hospital (NCCH)
2021-06-08
Jun 8, 2021M
Recruiting
- Leukemia, Myeloid, Acute
- Outpatient Care Model
- CPX-351
- Milwaukee, WisconsinFroedtert Hospital
2021-05-24
May 24, 2021U
Active, not recruiting
- Acute Myeloid Leukemia
- Behavioral: UR-GOAL communication tool
- Rochester, New YorkUniversity of Rochester Medical Center
2022-03-15
Mar 15, 2022P
Completed
- Leukemia, Myeloid, Acute
- Gemtuzumab Ozogamicin
- New York, New YorkPfizer Investigational Site
2021-07-16
Jul 16, 2021G
Recruiting
- Acute Myeloid Leukemia
- NanJing, ChinaDepartment of Hematology, Zhongda Hospital, Medical School of So
2022-03-22
Mar 22, 2022U
Recruiting
- Acute Myeloid Leukemia
- Aurora, ColoradoUniverstiy of Colorado Hospital
2022-02-15
Feb 15, 2022H
Recruiting
- Leukemia, Myeloid
- Demonstration of T cell responses
- Pierre-Bénite, FranceHôpital Lyon Sud
2021-07-26
Jul 26, 2021M
Available
- Acute Myeloid Leukemia
- +2 more
- flotetuzumab
- (no location specified)
2021-08-18
Aug 18, 2021J
Completed
- Leukemia, Myeloid, Acute
- Fukushima, Japan
- +5 more
2021-12-16
Dec 16, 2021U
Suspended
- Acute Myeloid Leukemia
- Integrative Therapy
- Gainesville, FloridaUniversity of Florida
2022-01-14
Jan 14, 2022